Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista Ciências em Saúde |
Texto Completo: | https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1389 |
Resumo: | Introduction: Metabolic syndrome (MetS) predicts cardiovascular disease, and patients with this condition and type 2 diabetes have increased albuminuria, significantly impacting cardiovascular mortality and kidney disease progression. A considerable number of interventions to control MetS exist and are considered efficient, including the use of medication and changes in lifestyle. However, which approaches are effective in controlling albuminuria remains unclear. This systematic review protocol aims to map in the available literature whether lifestyle, medication, and surgical intervention for MetS have an impact on reducing albuminuria in adult patients. Methods: The Joanna Briggs Institute methodology for systematic reviews will be followed. Cochrane Database of Systematic Reviews, Scopus, Embase, and MEDLINE/PubMed databases will be used. For the Gray Literature, the DART-Europe E-theses Portal. There will be no language restriction. Studies written after 2009 will be included due to the consensus and definition of metabolic syndrome. This review will include studies considering pharmacological and non-pharmacological treatments for controlling albuminuria in patients with MetS. Studies where MetS is described in children and adolescents, animals, pregnant women, and patients with type 1 diabetes will be excluded. First, the selection will be based on reading the title and summary of the texts retrieved in the search strategy, followed by reading the relevant texts in full by two reviewers. After the selection of the studies, the extraction of the data, analysis, and synthesis will be conducted according to the JBI methodology. |
id |
RCS_139528282c378b0ae8a79f21486570ca |
---|---|
oai_identifier_str |
oai:ojs.portalrcs.hcitajuba.org.br:article/1389 |
network_acronym_str |
RCS |
network_name_str |
Revista Ciências em Saúde |
repository_id_str |
|
spelling |
Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocolmicroalbuminuriaproteinuriametabolic syndromealbuminuriatreatmentIntroduction: Metabolic syndrome (MetS) predicts cardiovascular disease, and patients with this condition and type 2 diabetes have increased albuminuria, significantly impacting cardiovascular mortality and kidney disease progression. A considerable number of interventions to control MetS exist and are considered efficient, including the use of medication and changes in lifestyle. However, which approaches are effective in controlling albuminuria remains unclear. This systematic review protocol aims to map in the available literature whether lifestyle, medication, and surgical intervention for MetS have an impact on reducing albuminuria in adult patients. Methods: The Joanna Briggs Institute methodology for systematic reviews will be followed. Cochrane Database of Systematic Reviews, Scopus, Embase, and MEDLINE/PubMed databases will be used. For the Gray Literature, the DART-Europe E-theses Portal. There will be no language restriction. Studies written after 2009 will be included due to the consensus and definition of metabolic syndrome. This review will include studies considering pharmacological and non-pharmacological treatments for controlling albuminuria in patients with MetS. Studies where MetS is described in children and adolescents, animals, pregnant women, and patients with type 1 diabetes will be excluded. First, the selection will be based on reading the title and summary of the texts retrieved in the search strategy, followed by reading the relevant texts in full by two reviewers. After the selection of the studies, the extraction of the data, analysis, and synthesis will be conducted according to the JBI methodology.Hospital de Clínicas de Itajubá2023-03-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer reviewedAvaliado pelos paresinfo:eu-repo/semantics/otherapplication/pdfapplication/pdfhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/138910.21876/rcshci.v13i1.1389Health Sciences Journal; v. 13 n. 1 (2023): Janeiro a Março de 2023; 22-25Health Sciences Journal; Vol 13 No 1 (2023): January to March 2023; 22-2510.21876/rcshci.v13i1reponame:Revista Ciências em Saúdeinstname:Hospital de Clínicas de Itajubáinstacron:HCIenghttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1389/865https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1389/866Copyright (c) 2023 Health Sciences Journalhttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessPeralva, Bárbara LouresSantos, Kelli Borges dosLopes, Marina Guedes FragaLima, Mario Flávio Cardoso deSouza, Claudio Teodoro de2023-12-03T22:13:59Zoai:ojs.portalrcs.hcitajuba.org.br:article/1389Revistahttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zeroPUBhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/oaircs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br2236-37852236-3785opendoar:2023-12-03T22:13:59Revista Ciências em Saúde - Hospital de Clínicas de Itajubáfalse |
dc.title.none.fl_str_mv |
Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol |
title |
Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol |
spellingShingle |
Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol Peralva, Bárbara Loures microalbuminuria proteinuria metabolic syndrome albuminuria treatment |
title_short |
Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol |
title_full |
Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol |
title_fullStr |
Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol |
title_full_unstemmed |
Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol |
title_sort |
Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol |
author |
Peralva, Bárbara Loures |
author_facet |
Peralva, Bárbara Loures Santos, Kelli Borges dos Lopes, Marina Guedes Fraga Lima, Mario Flávio Cardoso de Souza, Claudio Teodoro de |
author_role |
author |
author2 |
Santos, Kelli Borges dos Lopes, Marina Guedes Fraga Lima, Mario Flávio Cardoso de Souza, Claudio Teodoro de |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Peralva, Bárbara Loures Santos, Kelli Borges dos Lopes, Marina Guedes Fraga Lima, Mario Flávio Cardoso de Souza, Claudio Teodoro de |
dc.subject.por.fl_str_mv |
microalbuminuria proteinuria metabolic syndrome albuminuria treatment |
topic |
microalbuminuria proteinuria metabolic syndrome albuminuria treatment |
description |
Introduction: Metabolic syndrome (MetS) predicts cardiovascular disease, and patients with this condition and type 2 diabetes have increased albuminuria, significantly impacting cardiovascular mortality and kidney disease progression. A considerable number of interventions to control MetS exist and are considered efficient, including the use of medication and changes in lifestyle. However, which approaches are effective in controlling albuminuria remains unclear. This systematic review protocol aims to map in the available literature whether lifestyle, medication, and surgical intervention for MetS have an impact on reducing albuminuria in adult patients. Methods: The Joanna Briggs Institute methodology for systematic reviews will be followed. Cochrane Database of Systematic Reviews, Scopus, Embase, and MEDLINE/PubMed databases will be used. For the Gray Literature, the DART-Europe E-theses Portal. There will be no language restriction. Studies written after 2009 will be included due to the consensus and definition of metabolic syndrome. This review will include studies considering pharmacological and non-pharmacological treatments for controlling albuminuria in patients with MetS. Studies where MetS is described in children and adolescents, animals, pregnant women, and patients with type 1 diabetes will be excluded. First, the selection will be based on reading the title and summary of the texts retrieved in the search strategy, followed by reading the relevant texts in full by two reviewers. After the selection of the studies, the extraction of the data, analysis, and synthesis will be conducted according to the JBI methodology. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-03-28 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer reviewed Avaliado pelos pares info:eu-repo/semantics/other |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1389 10.21876/rcshci.v13i1.1389 |
url |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1389 |
identifier_str_mv |
10.21876/rcshci.v13i1.1389 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1389/865 https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1389/866 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Health Sciences Journal https://creativecommons.org/licenses/by-nc-sa/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Health Sciences Journal https://creativecommons.org/licenses/by-nc-sa/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Hospital de Clínicas de Itajubá |
publisher.none.fl_str_mv |
Hospital de Clínicas de Itajubá |
dc.source.none.fl_str_mv |
Health Sciences Journal; v. 13 n. 1 (2023): Janeiro a Março de 2023; 22-25 Health Sciences Journal; Vol 13 No 1 (2023): January to March 2023; 22-25 10.21876/rcshci.v13i1 reponame:Revista Ciências em Saúde instname:Hospital de Clínicas de Itajubá instacron:HCI |
instname_str |
Hospital de Clínicas de Itajubá |
instacron_str |
HCI |
institution |
HCI |
reponame_str |
Revista Ciências em Saúde |
collection |
Revista Ciências em Saúde |
repository.name.fl_str_mv |
Revista Ciências em Saúde - Hospital de Clínicas de Itajubá |
repository.mail.fl_str_mv |
rcs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br |
_version_ |
1797068960317833216 |